Clark Financial Services Group Inc. BD Takes Position in Cencora, Inc. $COR

Clark Financial Services Group Inc. BD acquired a new position in shares of Cencora, Inc. (NYSE:COR) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,549 shares of the company’s stock, valued at approximately $528,000.

A number of other hedge funds have also bought and sold shares of COR. United Bank lifted its holdings in Cencora by 4.5% in the second quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after buying an additional 305 shares during the period. Dorsey & Whitney Trust CO LLC grew its holdings in Cencora by 3.7% during the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 1,596 shares of the company’s stock worth $479,000 after acquiring an additional 57 shares during the period. Pinnacle Wealth Planning Services Inc. raised its position in shares of Cencora by 16.3% in the 2nd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,019 shares of the company’s stock worth $306,000 after acquiring an additional 143 shares in the last quarter. Empowered Funds LLC raised its position in shares of Cencora by 10.6% in the 2nd quarter. Empowered Funds LLC now owns 20,128 shares of the company’s stock worth $6,035,000 after acquiring an additional 1,922 shares in the last quarter. Finally, Wealthspire Advisors LLC acquired a new position in shares of Cencora in the 2nd quarter valued at about $425,000. Institutional investors own 97.52% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Leerink Partners restated an “outperform” rating on shares of Cencora in a research report on Tuesday. Wells Fargo & Company lifted their target price on Cencora from $405.00 to $429.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. JPMorgan Chase & Co. boosted their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Jefferies Financial Group upgraded Cencora from an “underperform” rating to a “buy” rating in a report on Thursday, January 22nd. Finally, Robert W. Baird set a $415.00 price objective on shares of Cencora in a research report on Tuesday, January 13th. Twelve equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $403.17.

Insider Transactions at Cencora

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of the business’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the sale, the chief executive officer owned 66,726 shares in the company, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.38% of the company’s stock.

Cencora Stock Performance

Shares of Cencora stock opened at $332.06 on Friday. The business has a 50-day simple moving average of $355.08 and a 200 day simple moving average of $339.36. Cencora, Inc. has a one year low of $264.33 and a one year high of $377.54. The company has a debt-to-equity ratio of 3.62, a current ratio of 0.92 and a quick ratio of 0.51. The firm has a market capitalization of $64.59 billion, a price-to-earnings ratio of 39.91, a PEG ratio of 1.51 and a beta of 0.68.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The business had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. During the same quarter in the prior year, the company earned $3.73 earnings per share. The company’s quarterly revenue was up 5.5% on a year-over-year basis. On average, research analysts anticipate that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is currently 28.85%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.